127 reports of this reaction
3.2% of all LIDOCAINE HCL reports
#3 most reported adverse reaction
PAIN is the #3 most commonly reported adverse reaction for LIDOCAINE HCL, manufactured by Chattem, Inc.. There are 127 FDA adverse event reports linking LIDOCAINE HCL to PAIN. This represents approximately 3.2% of all 3,987 adverse event reports for this drug.
LIDOCAINE HCL has an overall safety score of 72 out of 100. Patients taking LIDOCAINE HCL who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among LIDOCAINE HCL users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for LIDOCAINE HCL:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 127 FDA reports for LIDOCAINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.2% of all adverse event reports for LIDOCAINE HCL, making it one of the most commonly reported side effect.
If you experience pain while taking LIDOCAINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.